Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Study looking genomic antigen loss timing in myeloma treated with T-cell redirection finds biallelic loss driven by events after BCMA/GPRC5D CAR-T/TCE; in 752 NDMM patients 2.7% and 9%, respectively, had monoallelic inactivation.”
Title: Timing genomic antigen loss in multiple myeloma treated with T-cell redirecting immunotherapies
Authors: Marios Papadimitriou, Sungwoo Ahn, Benjamin T Diamond, Holly Lee, John B McIntyre, Marietta Truger, Michael A Durante, Bachisio Ziccheddu, Katalin Osz, Ola Landgren, Leo Rasche, Nizar J Bahlis, Paola Neri, Francesco Maura
More posts featuring Robert Orlowski on OncoDaily.
